コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 regulated by the transcription factor HIF-1 (hypoxia-inducible factor 1).
2 regulates Complex II expression and opposes hypoxia-inducible factor-1.
3 sion is mediated by the transcription factor hypoxia-inducible factor-1.
4 lly mediated at the transcriptional level by hypoxia-inducible factor-1.
5 ontaining family, pyrin domain-containing-3; hypoxia-inducible factor 1/2alpha; and NF-kappaB were al
7 phage glucose metabolism pathway via the Vpr-hypoxia inducible factor 1 alpha (HIF-1 alpha) axis to i
8 production of reactive oxygen species (ROS), hypoxia inducible factor 1 alpha (HIF-1alpha), and its t
9 mphedema, there is a significant increase of hypoxia inducible factor 1 alpha (HIF-1alpha), but a red
10 protein levels in macrophages and T cells of hypoxia inducible factor 1 alpha (HIF-1alpha), the regul
11 ovascular, resulting in the up-regulation of hypoxia inducible factor 1 alpha (HIF1A), which promotes
12 entified in this screen, only one candidate, hypoxia inducible factor 1 alpha (Hif1alpha), did not ha
13 from hydroxylating the transcription factor hypoxia inducible factor 1 alpha (HIF1alpha), targeting
15 found that E2 and PPT induced the binding of hypoxia inducible factor 1 alpha subunit (HIF1A) in the
16 ine production of VEGF with the induction of hypoxia inducible factor-1 alpha (HIF-1 alpha) and survi
17 control, and immunohistochemical staining of hypoxia inducible factor-1 alpha (HIF-1 alpha), vascular
20 nd it was accompanied by decreased levels of hypoxia inducible factor-1 alpha (HIF-1alpha) and Bcl-2.
22 poxia-inducible angiogenic pathway involving hypoxia inducible factor-1 alpha (HIF-1alpha), vascular
26 trol, inhibition of PHD2 increased levels of hypoxia inducible factor-1 alpha protein and several dow
29 ationship for the VHL tumor suppressor gene, hypoxia inducible factor-1 alpha, and vascular endotheli
31 ngiogenic factors were partially mediated by hypoxia-inducible factor 1 alpha (HIF-1alpha) and recomb
33 oenvironments where the stabilization of the hypoxia-inducible factor 1 alpha (Hif-1alpha) subunit is
34 posttranscriptional control of expression of hypoxia-inducible factor 1 alpha (HIF-1alpha), a critica
35 not only that LOXL2 was regulated by hypoxia/hypoxia-inducible factor 1 alpha (HIF-1alpha), but also
42 sents a common pathway for the regulation of hypoxia-inducible factor 1 alpha (HIF1alpha)-dependent V
43 nd STAT6 phosphorylation, and down-regulated hypoxia-inducible factor 1 alpha and its downstream targ
44 activity associated with induction of tumor hypoxia-inducible factor 1 alpha expression and marked i
45 utyrate (SB) may indirectly (through reduced hypoxia-inducible factor 1 alpha stabilization) decrease
46 lower expression of lactate dehydrogenase 5, hypoxia-inducible factor 1 alpha subunit, and vascular e
47 activated phenotype (increased expression of hypoxia-inducible factor 1 alpha, glucose transporter 1,
48 ealed that mTOR controls the accumulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and the c
49 asts were hypersensitive to the induction of hypoxia-inducible factor-1 alpha (HIF-1 alpha) under hyp
50 EP1 receptor up-regulates the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha), which ca
52 hown to reduce oxidative stress and increase hypoxia-inducible factor-1 alpha (HIF-1alpha) activation
54 eport that tamoxifen decreases the levels of hypoxia-inducible factor-1 alpha (HIF-1alpha) and the sy
55 ngiogenic effect, CSCs were transfected with hypoxia-inducible factor-1 alpha (HIF-1alpha) by using e
58 conditions, HEXIM1 inhibits estrogen-induced hypoxia-inducible factor-1 alpha (HIF-1alpha) protein ex
59 that robustly and persistently expresses the hypoxia-inducible factor-1 alpha (HIF-1alpha) therapeuti
60 ially via direct and indirect effects of the hypoxia-inducible factor-1 alpha (HIF-1alpha) transcript
61 ng that cetuximab reduces cellular levels of hypoxia-inducible factor-1 alpha (HIF-1alpha), a transcr
62 hypoxic/ischemic retinal ganglion cells in a hypoxia-inducible factor-1 alpha (HIF-1alpha)-dependent
63 se inhibitors (PHI) promote stabilization of hypoxia-inducible factor-1 alpha and affect signaling ca
64 allogeneic recipients resulted in increased hypoxia-inducible factor-1 alpha expression and reduced
65 pimonidazole, macrophage marker RAM-11, and hypoxia-inducible factor-1 alpha subunit [HIF-1alpha]).
66 e B), SRC, and overexpression of HIF1-alpha (hypoxia-inducible factor-1 alpha), survivin, and VWF (Vo
69 , vascular endothelial growth factor (VEGF), hypoxia-inducible factor 1-alpha (HIF-1alpha) and erythr
70 that the expression of NLRP3 is mediated by hypoxia-inducible factor 1-alpha (HIF-1alpha) during the
71 s to test whether constitutive expression of hypoxia-inducible factor 1-alpha (HIF-1alpha) influences
72 a mutated (ATM)-dependent phosphorylation of hypoxia-inducible factor 1-alpha (HIF-1alpha) on serine(
74 in physiological oxygen conditions through a hypoxia-inducible factor 1-alpha (HIF-1alpha)-dependent
77 miR-210 transcription was activated in an hypoxia-inducible factor 1-alpha (Hif1a)-dependent manne
78 nsiently increasing the transcription factor hypoxia-inducible factor 1-alpha (HIF1alpha) is required
79 mutant mice did not display accumulation of hypoxia-inducible factor 1-alpha (HIF1alpha), and deleti
81 1, and the downstream transcription factors hypoxia-inducible factor 1-alpha and c-Myc, which togeth
82 was associated with increased expression of hypoxia-inducible factor 1-alpha and glucose transporter
83 ation and decreased nuclear translocation of hypoxia-inducible factor 1-alpha and vascular endothelia
84 TLR-primed cells was dependent, in part, on hypoxia-inducible factor 1-alpha and was essential for i
85 e kinase release spectrophotometrically, and hypoxia-inducible factor 1-alpha by Western blotting.
88 tors nuclear factor of activated T cells and hypoxia-inducible factor 1-alpha in PAH-PASMCs, previous
93 y, Leu increases the intracellular levels of hypoxia-inducible factor 1-alpha, a repressor of endocri
94 eration, up-regulation of AKT signaling, and hypoxia-inducible factor 1-alpha-related angiogenesis.
98 ered to express tumor-necrosis-factor-alpha, hypoxia-inducible-factor-1-alpha antibodies, interleukin
99 d stress-induced activation of cardiomyocyte hypoxia inducible factor 1 and the release of vascular e
101 rect transcriptional target of oxygen-labile hypoxia-inducible factor 1 and 2 that accentuates the fo
103 owth factor (VEGF) and blocked activation of hypoxia-inducible factor-1 and nuclear factor-kappaB in
104 E were dependent on the transcription factor hypoxia-inducible factor-1 and on formation of a single-
110 ated their ability to respond to hypoxia via hypoxia-inducible factors 1 and 2, tumor relapse was una
111 up-regulating such transcription factors as hypoxia-inducible factors 1 and 2, which in turn activat
115 ith higher VEGF (3.65 vs. 5.98; P = 0.01) or hypoxia-inducible factor 1 expression (3.63 vs. 5.48; P
118 ntly, we demonstrated that factor-inhibiting hypoxia-inducible factor 1 (FIH-1) diminished glycogen s
119 dies with the hydroxylase, factor inhibiting hypoxia-inducible factor 1 (FIH-1), we observed increase
120 n undergo hydroxylation by factor-inhibiting hypoxia-inducible factor 1 (FIH-1); however, the biologi
127 lpha (AMPKalpha) degradation, (ii) increased hypoxia inducible factor-1 (HIF-1) alpha expression, and
128 ators have been identified for its promoter: hypoxia inducible factor-1 (HIF-1) and signal transducer
129 nical data provides evidence for the role of hypoxia inducible factor-1 (HIF-1) as a crucial mediator
133 with tumor resistance to therapy and express hypoxia inducible factor-1 (HIF-1), a transcription fact
140 alpha-ketoglutarate antagonist that induces hypoxia-inducible factor 1 (HIF-1) activity, results in
142 ugh activation of transcription factors like hypoxia-inducible factor 1 (HIF-1) and c-Myc, yet the im
145 ROS production, we showed that ROS regulated hypoxia-inducible factor 1 (HIF-1) and vascular endothel
148 response to hypoxia in many cell types, and hypoxia-inducible factor 1 (HIF-1) has been implicated i
152 rus encoding a constitutively active form of hypoxia-inducible factor 1 (HIF-1) induced VEGFR1 mRNA a
168 recent work delineating mechanisms by which hypoxia-inducible factor 1 (HIF-1) mediates adaptive met
174 Being key regulator of oxygen homeostasis hypoxia-inducible factor 1 (HIF-1) plays significant rol
175 y demonstrated that the transcription factor hypoxia-inducible factor 1 (HIF-1) promotes the onset of
176 der conditions of reduced O(2) availability, hypoxia-inducible factor 1 (HIF-1) reciprocally regulate
179 r concentrations of thioredoxin 1 (Trx1) and hypoxia-inducible factor 1 (HIF-1) than cells from unsup
180 Here, we delineate a pathway controlled by hypoxia-inducible factor 1 (HIF-1) that epigenetically a
181 EN increases the transcriptional activity of hypoxia-inducible factor 1 (HIF-1) through the inactivat
182 ated, our results point to the activation of hypoxia-inducible factor 1 (HIF-1) upon HIV-1 infection
184 uestion and reveal that orexin activates the hypoxia-inducible factor 1 (HIF-1), a heterodimeric tran
187 ia-induced amoeboid detachment was driven by hypoxia-inducible factor 1 (HIF-1), followed the downreg
188 ons requires transcription through activated hypoxia-inducible factor 1 (HIF-1), increased mRNA stabi
189 adhesion molecule 1, IL-10, heme oxygenase 1 hypoxia-inducible factor 1 (HIF-1), monocyte chemotactic
190 g the relationship between the activation of hypoxia-inducible factor 1 (HIF-1), the primary transcri
192 rs increased production of erythropoietin by hypoxia-inducible factor 1 (HIF-1), which is a transcrip
193 A low dose of either H2S or HCN can activate hypoxia-inducible factor 1 (HIF-1), which is required fo
194 hypoxic pulmonary hypertension (HPH) include hypoxia-inducible factor 1 (HIF-1)-dependent transactiva
195 cin and daunorubicin as potent inhibitors of hypoxia-inducible factor 1 (HIF-1)-mediated gene transcr
206 ion regulates glycolysis in cancer cells via hypoxia-inducible factor 1 (HIF-1alpha) and its transcri
207 own-regulated sFlt1 production by inhibiting hypoxia-inducible factor 1 (HIF-1alpha) protein expressi
209 Here, we report that balanced activity of hypoxia-inducible factor-1 (HIF-1) and HIF-2 is critical
210 of the KRAS mutations and for expression of hypoxia-inducible factor-1 (HIF-1) and minichromosome ma
212 In this report, we address the dynamics of hypoxia-inducible factor-1 (HIF-1) binding to the vascul
215 of this study was to establish the effect of hypoxia-inducible factor-1 (HIF-1) directly on tumor gro
217 to accumulation of the transcription factor hypoxia-inducible factor-1 (HIF-1) in skeletal muscle ce
218 (NF-kappaB), activator protein-1 (AP-1), and hypoxia-inducible factor-1 (HIF-1) in the hypoxic regula
219 Here we report that 1 h of HT activates hypoxia-inducible factor-1 (HIF-1) in tumors and its dow
228 a potent stimulator of VEGF expression, and hypoxia-inducible factor-1 (HIF-1) is considered to be c
239 ated during hypoxia due to direct binding by hypoxia-inducible factor-1 (HIF-1) to HIF-1 response ele
240 LOX in colorectal cancer synergizes with hypoxia-inducible factor-1 (HIF-1) to promote tumor prog
241 ion of gene expression occurs mainly via the hypoxia-inducible factor-1 (HIF-1) transcription factor
242 rubicin (DXR) and daunorubicin (DNR) inhibit hypoxia-inducible factor-1 (HIF-1) transcriptional activ
243 Digoxin and other cardiac glycosides inhibit hypoxia-inducible factor-1 (HIF-1) transcriptional activ
244 the effects of pharmacological inhibition of hypoxia-inducible factor-1 (HIF-1), a critical regulator
246 These tumor cells are hypoxic and express hypoxia-inducible factor-1 (HIF-1), a prosurvival transc
247 rimary factor mediating this response is the hypoxia-inducible factor-1 (HIF-1), an oxygen-sensitive
248 -kappaB), STAT3, activator protein-1 (AP-1), hypoxia-inducible factor-1 (HIF-1), and tumor protein 53
249 suppresses hypoxia-sensitive genes, e.g. via hypoxia-inducible factor-1 (HIF-1), but mutations in Com
250 ecular key players in tumor hypoxia, such as hypoxia-inducible factor-1 (HIF-1), have been discovered
251 cellular response, the transcription factor hypoxia-inducible factor-1 (HIF-1), is correlated with p
252 bunit of the host cell transcription factor, hypoxia-inducible factor-1 (HIF-1), is up-regulated by i
253 tivation in transcription are dependent upon hypoxia-inducible factor-1 (HIF-1), whereas others are H
254 y and voltage dependency as full-length, was hypoxia-inducible factor-1 (HIF-1)-dependent and could b
255 Hypoxia-induced angiogenesis is mediated by hypoxia-inducible factor-1 (HIF-1)-dependent transcripti
260 nds the functional NF-kappaB binding site in hypoxia-inducible factor-1 (HIF-1alpha) promoter and res
262 tidinyl hydroxylase FIH-1 (factor inhibiting hypoxia-inducible factor 1 [HIF-1]), the lysyl hydroxyla
263 alt chloride (CoCl(2), a chemical inducer of hypoxia-inducible factor 1, HIF-1), suggesting a regulat
264 elanoma and clear cell sarcoma cells through hypoxia inducible factor 1 (HIF1)-mediated induction of
271 is increased by pharmacologic inhibition of hypoxia-inducible factor 1 (HIF1) or its target gene pyr
272 family of transcription factors, among which hypoxia-inducible factor 1 (HIF1) plays a major role.
273 In exercise, as well as cancer and ischemia, hypoxia-inducible factor 1 (HIF1) transcriptionally acti
274 the metabolic reprogramming associated with hypoxia-inducible factor 1 (HIF1), as constitutive activ
275 cancer cells was under strict control of the hypoxia-inducible factor 1 (HIF1), which drove redox- an
282 ption, lactate production, and expression of Hypoxia-inducible factor 1 (HIF1alpha) target genes, sug
283 label exchange between pyruvate and lactate, hypoxia-inducible factor-1 (HIF1alpha), and the monocarb
284 by an oxygen-sensitive transcription factor, hypoxia-inducible factor-1 (HIF1alpha), which becomes ac
286 cIH induced systemic insulin resistance in a hypoxia-inducible factor 1-independent manner and impair
287 P=9.8x10(-10)) and HIF1AN (factor inhibiting hypoxia-inducible factor-1; P=5.7x10(-9)) polymorphisms
288 oxide dismutase (SOD2), increases HIF1alpha (hypoxia-inducible factor-1), reduces endothelial cadheri
289 dermal growth factor receptor-MAP/ERK kinase-hypoxia-inducible factor 1 signaling but on RhoA pathway
292 he stricture phenotype of ISMC showed stable hypoxia inducible factor 1 subunit alpha expression that
294 g axis towards glycolysis with activation of hypoxia-inducible factor 1 subunit alpha (HIF-1alpha) an
295 We measured levels and stability of the hypoxia-inducible factor 1 subunit alpha (HIF1A), endoth
296 t of a transcriptional complex involving the hypoxia-inducible factor-1 transcription factor, p300, R
297 d by mTORC1 regulate the expression of HIF1 (hypoxia-inducible factor 1) transcription factor complex
298 y foci, evidencing induction of an epidermal hypoxia-inducible factor-1 transcriptional program, and
300 f asTF is mediated via the activation of the hypoxia-inducible factor-1/vascular endothelial growth f